Susan Swetter, M.D.

Clinical Focus

• Cancer> Cutaneous (Dermatologic) Oncology
• Basal / Squamous Cell Carcinomas
• Basal / Squamous Cell Carcinomas - Dermatology
• Cutaneous Oncology
• Dermatology

Administrative Appointments

• President, Board of Directors, American Cancer Society, Santa Clara County Unit (2009 - 2011)
• Member, Melanoma/Skin Cancer Committee, American Academy of Dermatology (1999 - 2009)
• Member, Scientific Programs Committee, Melanoma Section, American Society of Clinical Oncology (2006 - 2008)
• Member, Melanoma Clinical Guidelines Task Force, American Academy of Dermatology (2006 - 2011)
• Member, Melanoma Panel, National Comprehensive Cancer Network (2007 - 2011)

Honors and Awards

• Nominated, Franklin G. Ebaugh, Jr. Award (outstanding dedication to advising medical students), Stanford University School of Medicine (1999, 2001, 2004, 2009)
• Nominated, Kaiser Award for Clinical Teaching, Stanford University School of Medicine (2003, 2004, 2005)
• Recognition for Excellence in Teaching, Stanford University School of Medicine (2004, 2009)
• Leadership Award, Melanoma Care Coalition (2007)
• President�s Volunteer Service Award, President�s Council on Service & Civic Participation, Corporation for National & Community Service (2007)

Professional Education

Graduate & Fellowship Program Affiliations

• Dermatology

Community & International Work

• President, Board of Directors, American Cancer Society Santa Clara County Unit, Campbell, CA 
• Program Director, Stanford Skin Cancer Screening Program, 1995-present, Stanford Medicine Outpatient Clinics 

Internet Links

• Stanford Cancer Center - Melanoma Program

Current Research Interests

Dr. Swetter has directed the Pigmented Lesion and Melanoma Programs at Stanford University Medical Center and Cancer Center and VA Palo Alto since 1995. She serves as the national dermatology liaison to the Eastern Cooperative Oncology Group (ECOG) Melanoma Committee and Co-Chairs the Melanoma Prevention Working Group, a national forum for research collaboration among academic oncologists, dermatologists, epidemiologists, and surgeons dedicated to cancer control and prevention, and currently comprised of 29 Intergroup (ECOG, SWOG, CALGB) melanoma centers in the US. Dr. Swetter's research interests include secondary prevention of melanoma, including early detection and screening of high-risk groups, melanoma chemoprevention in individuals with atypical mole syndrome, and research focused on increasing professional and public education to improve melanoma awareness. She is also engaged in clinical studies of the epidemiology, prognostic factors, and therapy of melanoma and nonmelanoma skin cancers.

Clinical Trials

• Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma Recruiting
• Expanded Access Ipilimumab (BMS-734016) Monotherapy in Unresectable Stage III or Stage IV Melanoma Recruiting
• Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Recruiting
• A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma No longer recruiting
• Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery Suspended

Publications

• Guidelines of care for the management of primary cutaneous melanoma. Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik JM, Swetter SM, Tsao H, Holloway Barbosa V, Chuang TY, Duvic M, Ho VC, Sober AJ, Beutner KR, Bhushan R, Begolka WS. J Am Acad Dermatol. 2011
• Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ, Longaker MT, Weissman IL. Nature. 2011; 470 (7334): 424
• Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Hausauer AK, Swetter SM, Cockburn MG, Clarke CA. Arch Dermatol. 2011; 147 (7): 783-9
• The expanding melanoma burden in California hispanics: Importance of socioeconomic distribution, histologic subtype, and anatomic location. Pollitt RA, Clarke CA, Swetter SM, Peng DH, Zadnick J, Cockburn M. Cancer. 2011; 117 (1): 152-61
• Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008. Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM. Pediatr Dermatol. 2010 May-Jun; 27 (3): 244-54